ORIGINAL ARTICLE
Transcultural adaptation and psychometric validation of the Female Sexual Function Index (FSFI) questionnaire in the Kazakh population
 
More details
Hide details
1
Department of Obstetrics and Gynecology No. 2, NpJSC “Astana Medical University”, Astana, KAZAKHSTAN
 
 
Online publication date: 2023-08-20
 
 
Publication date: 2023-11-01
 
 
Electron J Gen Med 2023;20(6):em540
 
KEYWORDS
ABSTRACT
Introduction:
Sexual dysfunction associated with pelvic organ prolapse (POP) is common and validated questionnaires for assessment are recommended.

Aim:
To develop and validate the Kazakh-translated version of the female sexual function index (Kz-FSFI).

Methods:
Kz-FSFI was translated from the original version for validation, and its precision was ascertained through reverse translation by an expert team. 35 sexually active females participated in an evaluation of the test-retest reliability of the Kazakh version over a two-week period. In the next stage, 110 healthy women and 40 patients with POP aged 18-55 years were enrolled in the study. The validity, internal consistency reliability and test-retest reliability of the questionnaires were assessed.

Results:
The cross-cultural adaptation of Kz-FSFI achieved good semantic, conceptual, idiomatic and content equivalence. The test-retest reliability was shown to be high in all of the cases (p<0.001). Cronbach’s alpha coefficients for total and domain scores were sufficiently high (range 0.85-0.94) for the total sample. The discriminant validity showed statistically significant differences between patients with POP-associated sexual dysfunctions and the control group.

Conclusions:
Kz-FSFI questionnaire is a valuable tool for screening women with sexual dysfunction. As this questionnaire had validity in the Kazakhstan survey, it could be used for medical counselling and future investigation in our country.

 
REFERENCES (35)
1.
WHO. Sexual health: Working definitions. World Health Organization; 2002. Available at: http://www.who.int/reproductiv... (Accessed: 8 November 2013).
 
2.
Nappi RE, Lachowsky M. Menopause and sexuality: Prevalence of symptoms and impact on quality of life. Maturitas. 2009;63(02):138-41. https://doi.org/10.1016/j.matu... PMid:19464129.
 
3.
Rosen R, Brown C, Heiman J, et al. The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther. 2000;26:191-208. https://doi.org/10.1080/009262... PMid:10782451.
 
4.
Lewis RW, Fugl-Meyer KS, Corona G, et al. Definitions/epidemiology/risk factors for sexual dysfunction. J Sex Med. 2010;7(4 Pt 2):1598-607. https://doi.org/10.1111/j.1743... PMid:20388160.
 
5.
McCabe MP, Sharlip ID, Lewis R, et al. Risk factors for sexual dysfunction among women and men: A consensus statement from the fourth international consultation on sexual medicine. J Sex Med. 2016;13:153-67. https://doi.org/10.1016/j.jsxm... PMid:26953830.
 
6.
Verbeek M, Hayward L. Pelvic floor dysfunction and its effect on quality of sexual life. Sex Med Rev. 2009;7(4):559-64. https://doi.org/10.1016/j.sxmr... PMid:31351916.
 
7.
Mollaioli D, Ciocca G, Limoncin E, et al. Lifestyles and sexuality in men and women: The gender perspective in sexual medicine. Reprod Biol Endocrinol. 2020;18(1):10. https://doi.org/10.1186/s12958... PMid:32066450 PMCid:PMC7025405.
 
8.
US Food and Drug Administration. Female sexual dysfunction: Clinical development of drug products for treatment. 2000. Washington, DC: US FDA.
 
9.
Fakhri A, Pakpour AH, Burri A, Morshedi H, Zeidi IM. The female sexual function index: Translation and validation of an Iranian version. J Sex Med. 2012;9:514-23. https://doi.org/10.1111/j.1743... PMid:22146084.
 
10.
Sidi H, Abdullah N, Puteh SE, Midin M. The female sexual function index (FSFI): Validation of the Malay version. J Sex Med. 2007;4:1642-54. https://doi.org/10.1111/j.1743... PMid:17608666.
 
11.
Takahashi M, Inokuchi T, Watanabe C, Saito T, Kai I. The female sexual function index (FSFI): Development of a Japanese version. J Sex Med. 2011;8:2246-54. https://doi.org/10.1111/j.1743... PMid:21492402.
 
12.
Sun X, Li C, Jin L, Fan Y, Wang D. Development and validation of Chinese version of female sexual function index in a Chinese population–A pilot study. J Sex Med. 2011;8:1101-11. https://doi.org/10.1111/j.1743... PMid:21235720.
 
13.
ter Kuile MM, Brauer M, Laan E. The female sexual function index (FSFI) and the female sexual distress scale (FSDS): Psychometric properties within a Dutch population. J Sex Marital Ther. 2006;32:289-304. https://doi.org/10.1080/009262... PMid:16709550.
 
14.
Baser RE, Li Y, Carter J. Psychometric validation of the female sexual function index (FSFI) in cancer survivors. Cancer. 2012;118:4606-18. https://doi.org/10.1002/cncr.2... PMid:22359250.
 
15.
Verit FF, Verit A. Validation of the female sexual function index in women with chronic pelvic pain. J Sex Med. 2007;4:1635-41. https://doi.org/10.1111/j.1743... PMid:17888066.
 
16.
Chang SR, Chang TC, Chen KH, Lin HH. Developing and validating a Taiwan version of the female sexual function index for pregnant women. J Sex Med. 2009;6:1609-16. https://doi.org/10.1111/j.1743... PMid:19473461.
 
17.
Maasoumi R, Rahimi F, Naghizadeh S. Translation and validation of Persian version of sexual function: Vaginal changes questionnaire (SVQ) for women with gynecologic cancers. BMC Womens Health. 2022;22(1):283. https://doi.org/10.1186/s12905... PMid:35804312 PMCid:PMC9264581.
 
18.
Kazakhstan Bureau of National Statistics. Agency for strategic planning and reforms of the Republic of Kazakhstan Bureau of National Statistics. Available at: https://www.stat.gov.kz/ (Accessed: 8 November 2013).
 
19.
Basson R, Wierman ME, van Lankveld J, Brotto L. Summary of the recommendations on sexual dysfunctions in women. J Sex Med. 2010;7:314-26. https://doi.org/10.1111/j.1743... PMid:20092441.
 
20.
Chedraui P, Pe’rez-Lo’pez FR, Mezones-Holguin E, San Miguel G, Avila C. Assessing predictors of sexual function in mid-aged sexually active women. Maturitas. 2011;68(4): 387-90. https://doi.org/10.1016/j.matu... PMid:21237590.
 
21.
Aslan E, Beji NK, Gungor I, Kadioglu A, Dikencik BK. Prevalence and risk factors for low sexual function in women: A study of 1,009 women in an outpatient clinic of a university hospital in Istanbul. J Sex Med. 2008;5(9):2044-52. https://doi.org/10.1111/j.1743... PMid:18564155.
 
22.
Esposito K, Ciotola M, Giugliano F, et al. Association of body weight with sexual function in women. Int J Impot Res. 2007;19(4):353-7. https://doi.org/10.1038/sj.iji... PMid:17287832.
 
23.
Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for ptient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value Health. 2005;8(2):94-104. https://doi.org/10.1111/j.1524... PMid:15804318.
 
24.
Harvey M-A, Chih HJ, Geoffrion R, et al. International urogynecology consultation chapter 1 committee 5: Relationship of pelvic organ prolapse to associated pelvic floor dysfunction symptoms: Lower urinary tract, bowel, sexual dysfunction and abdominopelvic pain. Int Urogynecol J. 2021;32(10):2575-94. https://doi.org/10.1007/s00192... PMid:34338825.
 
25.
Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10-7. https://doi.org/10.1016/S0002-... PMid:8694033.
 
26.
Fayers P, Machin D. Quality of life: The assessment, analysis and interpretation of patient-reported outcomes. John Wiley & Sons; 2007.
 
27.
Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychol Rep. 1966;19(1):3-11. https://doi.org/10.2466/pr0.19... PMid:5942109.
 
28.
Hock M, Farkas N, Tiringer I, Gitta S, Németh Z, Farkas B. Validation and translation of the Hungarian version of the female sexual function index (FSFI-H). Int Urogynecol J. 2019;30(12):2109-20. https://doi.org/10.1007/s00192... PMid:31359116 PMCid:PMC6861199.
 
29.
Zachariou A, Filiponi M, Kirana PS. Translation and validation of the Greek version of the female sexual function index questionnaire. Int J Impot Res. 2017;29(4):171-4. https://doi.org/10.1038/ijir.2... PMid:28424501.
 
30.
Filocamo MT, Serati M, Li Marzi V, et al. The female sexual function index (FSFI): Linguistic validation of the Italian version. J Sex Med. 2014;11(2):447-53. https://doi.org/10.1111/jsm.12... PMid:24224761.
 
31.
Wylomanski S, Bouquin R, Philippe HJ, et al. Psychometric properties of the French female sexual function index (FSFI). Qual Life Res. 2014;23(7):2079-87. https://doi.org/10.1007/s11136... PMid:24585184.
 
32.
Rehman KU, Asif Mahmood M, Sheikh SS, Sultan T, Khan MA. The female sexual function index (FSFI): Translation, validation, and cross-cultural adaptation of an Urdu version “FSFI-U”. Sex Med. 2015;3(4):244-50. https://doi.org/10.1002/sm2.77 PMid:26797057 PMCid:PMC4721033.
 
33.
Browne MW, Cudeck R. Alternative ways of assessing model fit. Sociol Methods Res. 1992;21(2):230-58. https://doi.org/10.1177/004912....
 
34.
Vallejo-Medina P, Pérez-Durán C, Saavedra-Roa A. Translation, adaptation, and preliminary validation of the female sexual function index into Spanish (Colombia). Arch Sex Behav. 2018;47(3):797-810. https://doi.org/10.1007/s10508... PMid:28567567.
 
35.
Ho TTT, Le MT, Truong QV, Nguyen VQH, Cao NT. Validation of the Vietnamese translation version of the female sexual function index in infertile patients. Sex Med. 2020;8(1):57-64. https://doi.org/10.1016/j.esxm... PMid:31669053 PMCid:PMC7042161.
 
eISSN:2516-3507
Journals System - logo
Scroll to top